Li Xia
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Chongqing University of Posts and Telecommunications (2011); Dalian Ocean University (2007–2008); Jiangnan University (2024); University of North Carolina at Chapel Hill (2002); Nanjing Agricultural University (2014); United States Food and Drug Administration (2025); Central South University (2007–2011); University of Electronic Science and Technology of China (2022–2023); Harbin Medical University (2011); Shanghai Jiao Tong University (2021–2023); Yunnan Agricultural University (2007); Wuhan University of Technology (2021); Chinese Academy of Sciences (2023); Tianjin Foreign Studies University (2012); Qufu Normal University (2011); Purdue University West Lafayette (2024); Fudan University (2003–2022); WuXi AppTec (China) (2024); Tianjin Medical University Cancer Institute and Hospital (2016); Hefei Institutes of Physical Science (2023); Southwest Medical University (2023); China University of Geosciences (2011); Sichuan Agricultural University (2008); Anshan Normal University (2007–2011); Affiliated Hospital of Southwest Medical University (2023); Jiangsu Academy of Agricultural Sciences (2014); Mianyang Central Hospital (2022); Burke Medical Research Institute (2005–2010); Sichuan Cancer Hospital (2023); Wuxi No.2 People's Hospital (2024); Chinese Academy of Forestry (2020); Research Institute of Forestry (2020); Heze University (2020); Peking University Third Hospital (2024); Children's Hospital of Fudan University (2019–2021); First Hospital of Xi'an (2014); Guangdong Baiyun University (2012); University of Chinese Academy of Sciences (2007); UNC Lineberger Comprehensive Cancer Center (2002); State Key Laboratory of Tree Genetics and Breeding (2020); Laiwu Vocational and Technical College (2009); Tianjin Medical University (2016); Chongqing Jiaotong University (2018); Nanjing Medical University (2012); Xinjiang University of Finance and Economics (2007–2012)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Li Xia's research focuses on the molecular mechanisms underlying cellular processes, particularly the role of epigenetic modifications in gene regulation and disease. Xia has investigated histone methylation, including the purification and functional characterization of histone methyltransferases like SET8 and ESET. This work explores how these enzymes interact with transcription factors and influence gene expression codes. Further research has examined the impact of histone modifications, such as lysine 27 methylation, on gene silencing via Polycomb-group proteins. Xia's recent publications also delve into the interplay between metabolic processes, like glycolysis, and epigenetic modifications, such as histone lactylation, in driving oncogenesis. Additionally, Xia has explored the role of long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) in modulating immune responses, specifically M2 macrophage activation and inflammation, in conditions like asthma, atopic dermatitis, and psoriasis.
Metrics
- h-index: 16
- Publications: 104
- Citations: 5,755
Selected Publications
-
N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA (2025)
-
Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing (2025)
-
Genotoxicity of nanoparticles evaluated using the in vitro micronucleus assay, a review of recent data § (2025)
Collaboration Network
Top Collaborators
- Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
- Genotoxicity of nanoparticles evaluated using the <i>in vitro</i> micronucleus assay, a review of recent data <sup>§</sup>
- Genotoxicity of nanoparticles evaluated using the <i>in vitro</i> micronucleus assay, a review of recent data <sup>§</sup>
- Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing
- Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing
- Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
Similar Researchers
Based on overlapping research topics